Abstract
Botulinum toxin A was administered to 19 patients in a double-blind placebo controlled trial. Toxin was more effective than placebo for improving both head position and pain which was measured by an objective rating scale and videofilm assessments. Following the controlled trial, treatment with botulinum toxin was continued in an open fashion. A total of 60 patients with torticollis received toxin in a total of 117 treatment periods. The mean follow up period was 8.4 months. In 39 patients with pain there was benefit in 77% of treatment periods. Some improvement in neck posture occurred in 83% of the treatment periods with a mean duration of 12 weeks. Side effects were frequent with dysphagia being the most common (28% of treatment periods). Botulinum toxin is an effective treatment for toticollis but treatment should be initiated with doses at the lower end of the range used in this study (400-600 mouse units).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Black J. D., Dolly J. O. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol. 1986 Aug;103(2):521–534. doi: 10.1083/jcb.103.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brin M. F., Fahn S., Moskowitz C., Friedman A., Shale H. M., Greene P. E., Blitzer A., List T., Lange D., Lovelace R. E. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord. 1987;2(4):237–254. doi: 10.1002/mds.870020402. [DOI] [PubMed] [Google Scholar]
- Elston J. S. Botulinum toxin treatment of blepharospasm. Adv Neurol. 1988;50:579–581. [PubMed] [Google Scholar]
- Elston J. S., Russell R. W. Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed) 1985 Jun 22;290(6485):1857–1859. doi: 10.1136/bmj.290.6485.1857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jankovic J., Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology. 1987 Apr;37(4):616–623. doi: 10.1212/wnl.37.4.616. [DOI] [PubMed] [Google Scholar]
- Lange D. J., Brin M. F., Warner C. L., Fahn S., Lovelace R. E. Distant effects of local injection of botulinum toxin. Muscle Nerve. 1987 Jul-Aug;10(6):552–555. doi: 10.1002/mus.880100610. [DOI] [PubMed] [Google Scholar]
- Ludlow C. L., Naunton R. F., Sedory S. E., Schulz G. M., Hallett M. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology. 1988 Aug;38(8):1220–1225. doi: 10.1212/wnl.38.8.1220. [DOI] [PubMed] [Google Scholar]
- Nix W. A., Eckardt V. F., Krämer G. Reversible esophageal motor dysfunction in botulism. Muscle Nerve. 1985 Nov-Dec;8(9):791–795. doi: 10.1002/mus.880080908. [DOI] [PubMed] [Google Scholar]
- Stell R., Thompson P. D., Marsden C. D. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 1988 Jul;51(7):920–923. doi: 10.1136/jnnp.51.7.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TOURNAY A., PAILLARD J. Torticolis spasmodique et électromyographie. Rev Neurol (Paris) 1955;93(1):347–355. [PubMed] [Google Scholar]
- Tsui J. K., Eisen A., Calne D. B. Botulinum toxin in spasmodic torticollis. Adv Neurol. 1988;50:593–597. [PubMed] [Google Scholar]
- Tsui J. K., Eisen A., Mak E., Carruthers J., Scott A., Calne D. B. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci. 1985 Nov;12(4):314–316. doi: 10.1017/s031716710003540x. [DOI] [PubMed] [Google Scholar]
- Tsui J. K., Fross R. D., Calne S., Calne D. B. Local treatment of spasmodic torticollis with botulinum toxin. Can J Neurol Sci. 1987 Aug;14(3 Suppl):533–535. doi: 10.1017/s0317167100038063. [DOI] [PubMed] [Google Scholar]